5/2/2018 USITC - MTBPS Petition - 79 Miscellaneous Tariff Bill Petition (MTBP) Temporarily suspend the duty on certain o-Acetylsalicylic acid (Aspirin) Petition Id: 79 Date of Submission: October 14, 2016 3:35:34 PM EDT (1) Petitioner Information (1) Let's get started. Please enter the petitioner information. Petitioner Company Company Name: Bayer HealthCare LLC Company Address: 100 Bayer Boulevard Whippany NJ 07981 Petitioner Contact Contact Information: Steve Johnsen President, Bayer International Trade Services Corp 412-777-5616 (2) Independent Rep. Information (2) Are you an independent representative of the petitioner? No The Commission recognizes that petitioners may retain outside assistance to file a petition (e.g. a lawyer or consultant). (3) HTS Number (3) What HTS number applies to the product? This is the HTS eight-digit subheading that describes the product that is the subject of the petition in its condition as imported (e.g., physical characteristics) into the customs territory of the United States. Special characters may not render properly in the article description or rate of duty. HTS number Article description Rate of duty 2918.22.10.00 O-Acetylsalicylic acid (Aspirin) 6.5% https://mtbps.usitc.gov/external/petitions/petition/79.html#view-summary 1/5 5/2/2018 USITC - MTBPS Petition - 79 (4) Rate of Duty (4) Are you requesting a temporary duty suspension or a reduction? Suspension You are requesting a temporary duty suspension. The system will automatically consider your requested rate to be 0% (or "Free" for purposes of the legislative text). Rate of duty: Free (5) Chapter 99 (5) Does an expired provision in chapter 99 apply? Yes Please provide the HTS 8-digit number if the product was previously subject to a temporary duty suspension or reduction. Special characters may not render properly in the article description or rate of duty. HTS number Article description Rate of duty 9902.12.11 o-Acetylsalicylic acid (Aspirin) (CAS No. 50-78-2) (provided for in subheading 2918.22.10) 3.0% (6) Legislative Text (6) What is the proposed article description? Stat. Heading/ SufSubheading fix 9902.12.11 (7) 1/ Article Description o-Acetylsalicylic acid (Aspirin) (CAS No. 50-78-2) (provided for in subheading 2918.22.10) Unit of Quantity 1/ Rates of Duty 1 General Free Special 2 Effective Period No Change No Change On or before TBD Is your product a chemical? Yes If "Yes," please enter the relevant information for each constituent chemical. (8) CAS number IUPAC INN 50-78-2 2-acetoxybenzoic acid Aspirin CIN Is your product covered by multiple HTS numbers? No https://mtbps.usitc.gov/external/petitions/petition/79.html#view-summary 2/5 5/2/2018 USITC - MTBPS Petition - 79 (9) Ruling Information (9) Are you aware of a Customs ruling associated with this petition? Yes Is the Customs ruling public or private? published Please upload the associated rulings document: NY 890808.Aspirin.102293.pdf (../getAttachment?petitionId=79&type=R) (10) Import History (10) Has the petitioner previously imported the subject product? Yes If "YES," please provide Customs documentation (i.e. liquidated entry summary, Customs form 29, or other Customs documentation) supporting the product's classification for each HTS subheading you indicate above. Any document uploaded here will be treated as confidential business information, as defined in 19 CFR 201.6(a). CONFIDENTIAL (11) Usage Information Short Product Name and Description: (11.a) Short product name: o-Acetylsalicylic acid (Aspirin) (11.b) Product description: o-Acetylsalicylic acid (Aspirin) Product Use and Industry Description: (11.c) Product use description: o-Acetylsalicylic acid is used in the manufacturing of finished aspirin-containing medicine. Aspirin has a 115-year track record of safety and efficacy across a range of indications, including over-the-counter (OTC) pain relief and cardiovascular (CV) event prevention. Aspirin’s benefits in helping to prevent recurrent heart attacks, i.e., myocardial infarctions (“MI”), reducing the risk of death during a suspected acute MI, recurrent ischemic strokes and transient ischemic attacks (TIAs), among other approved CV indications such as revascularization procedures and chronic stable and unstable angina, are widely recognized. (11.d) Is this product an intermediate good (i.e., is it used to make another product)? Yes (11.e) Industry description: Consumer health, over-the-counter medicine industry. https://mtbps.usitc.gov/external/petitions/petition/79.html#view-summary 3/5 5/2/2018 USITC - MTBPS Petition - 79 (12) U.S. Import Information (12.a) From what country or countries is the product imported: Spain (12.b) Provide estimates of U.S. import data for the product for the previous calendar year, current calendar year, and for each of the next 5 years. If additional HTS numbers were entered in 7, fill out a separate table for each HTS number. CONFIDENTIAL (12.c) Are you aware of any other U.S. importers of the product? No (12.d) Are you aware of any beneficiaries other than the petitioner and U.S. importers listed above? No (12.e) Are you aware of any antidumping or countervailing duty orders or other additional duties (e.g., Section 201 or 301) on the product? (13) U.S. Production Information (13.a) Is an identical product produced in the United States? CONFIDENTIAL (13.b) Is there a like or directly competitive product produced in the United States? CONFIDENTIAL (13.c) If the product is produced in the United States, is it commercially available? CONFIDENTIAL (14) Additional Documentation (15) Certifications I certify that the petitioner is a likely beneficiary of the temporary duty suspension or reduction, if granted? Yes I certify that the proposed duty suspension or reduction is available to any person importing the article to which the proposed duty suspension or reduction would apply. Yes https://mtbps.usitc.gov/external/petitions/petition/79.html#view-summary 4/5 5/2/2018 https://mtbps.usitc.gov/external/petitions/petition/79.html#view-summary USITC - MTBPS Petition - 79 5/5